• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泼尼松和氢化可的松对人体内泼尼松龙血浆蛋白结合的影响。

The effect of prednisone and hydrocortisone on the plasma protein binding of prednisolone in man.

作者信息

Legler U F, Benet L Z

出版信息

Eur J Clin Pharmacol. 1986;30(1):51-5. doi: 10.1007/BF00614195.

DOI:10.1007/BF00614195
PMID:3709632
Abstract

The protein binding of prednisolone was studied in plasma obtained from healthy volunteers in the presence of added amounts of prednisone and hydrocortisone. The plasma protein binding was determined using in vitro equilibrium dialysis for 16 h at 37 degrees C against isotonic Krebs-Ringer buffer using radioactive prednisolone. Prednisone appeared to have no effect on prednisolone binding. This surprising result was observed even when prednisone concentrations were more than 35 fold greater than prednisolone concentrations. In contrast, a marked competition between hydrocortisone and prednisolone was observed. These binding data were fit using a nonlinear least squares regression computer program and the capacity and affinity constants for the binding of prednisolone to transcortin and albumin were estimated including the competition for binding sites between prednisolone and hydrocortisone. The results from these studies compare favorably with recent parameter calculations, and our previous work where differences in binding were noted between cushingoid and noncushingoid patients.

摘要

在添加了一定量泼尼松和氢化可的松的情况下,对健康志愿者的血浆中泼尼松龙的蛋白结合情况进行了研究。使用放射性泼尼松龙,在37℃下针对等渗的克雷布斯-林格缓冲液进行16小时的体外平衡透析,以测定血浆蛋白结合情况。泼尼松似乎对泼尼松龙的结合没有影响。即使泼尼松浓度比泼尼松龙浓度高出35倍以上,仍观察到这一令人惊讶的结果。相比之下,观察到氢化可的松与泼尼松龙之间存在明显的竞争。使用非线性最小二乘回归计算机程序对这些结合数据进行拟合,并估算了泼尼松龙与皮质转运蛋白和白蛋白结合的容量和亲和常数,包括泼尼松龙与氢化可的松之间对结合位点的竞争。这些研究结果与最近的参数计算结果以及我们之前的工作相比具有优势,在我们之前的工作中,注意到库欣综合征患者和非库欣综合征患者之间存在结合差异。

相似文献

1
The effect of prednisone and hydrocortisone on the plasma protein binding of prednisolone in man.泼尼松和氢化可的松对人体内泼尼松龙血浆蛋白结合的影响。
Eur J Clin Pharmacol. 1986;30(1):51-5. doi: 10.1007/BF00614195.
2
Endogenous and exogenous glucocorticoids in cushingoid patients.库欣综合征患者体内的内源性和外源性糖皮质激素。
Drug Intell Clin Pharm. 1982 Nov;16(11):863-8. doi: 10.1177/106002808201601109.
3
Plasma protein binding interaction of prednisone and prednisolone.泼尼松和泼尼松龙的血浆蛋白结合相互作用。
J Steroid Biochem. 1984 Sep;21(3):337-9. doi: 10.1016/0022-4731(84)90288-7.
4
Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.肾病综合征患者泼尼松龙的血浆蛋白结合发生改变。
Am J Kidney Dis. 1984 Mar;3(5):339-48. doi: 10.1016/s0272-6386(84)80081-5.
5
Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis.通过平衡透析研究影响泼尼松龙血浆蛋白结合的体液转移及其他因素。
J Pharm Sci. 1984 Jun;73(6):774-80. doi: 10.1002/jps.2600730617.
6
The nonlinear pharmacokinetics of prednisone and prednisolone. II. Plasma protein binding of prednisone and prednisolone in rabbit and human plasma.泼尼松和泼尼松龙的非线性药代动力学。II. 泼尼松和泼尼松龙在兔血浆和人血浆中的血浆蛋白结合情况。
Biopharm Drug Dispos. 1987 May-Jun;8(3):261-72. doi: 10.1002/bdd.2510080307.
7
The macromolecular binding of prednisone in plasma of healthy volunteers including pregnant women and oral contraceptive users.泼尼松在包括孕妇和口服避孕药使用者在内的健康志愿者血浆中的大分子结合情况。
J Pharmacokinet Biopharm. 1985 Dec;13(6):561-9. doi: 10.1007/BF01058901.
8
Serum protein binding of prednisolone in four species.
J Pharm Sci. 1980 Aug;69(8):977-8. doi: 10.1002/jps.2600690831.
9
Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.接受长期泼尼松治疗的免疫疾病患者中泼尼松龙的血浆蛋白结合参数。
J Lab Clin Med. 1981 Apr;97(4):487-501.
10
Simultaneous competitive protein binding assay for cortissol, cortisone, and prednisolone in plasma, and its clinical application.血浆中皮质醇、可的松和泼尼松龙的同步竞争性蛋白结合测定及其临床应用。
Clin Chem. 1973 Jul;19(7):731-6.

引用本文的文献

1
A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma.一种预测人血浆中总泼尼松龙浓度的药代动力学/药效学方法。
J Pharmacokinet Pharmacodyn. 2007 Jun;34(3):355-72. doi: 10.1007/s10928-007-9050-8. Epub 2007 Feb 23.
2
Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.
Eur J Clin Pharmacol. 1993;44(4):395-9. doi: 10.1007/BF00316481.
3
The macromolecular binding of prednisone in plasma of healthy volunteers including pregnant women and oral contraceptive users.泼尼松在包括孕妇和口服避孕药使用者在内的健康志愿者血浆中的大分子结合情况。

本文引用的文献

1
Ultrafiltration studies of steroid-protein binding.类固醇 - 蛋白质结合的超滤研究
J Endocrinol. 1961 Oct;23:129-37. doi: 10.1677/joe.0.0230129.
2
Prednisolone disposition in steroid-dependent asthmatics.
J Allergy Clin Immunol. 1980 Nov;66(5):366-73. doi: 10.1016/0091-6749(80)90115-3.
3
Prednisolone clearance at steady state in man.
J Clin Endocrinol Metab. 1982 Oct;55(4):762-7. doi: 10.1210/jcem-55-4-762.
4
J Pharmacokinet Biopharm. 1985 Dec;13(6):561-9. doi: 10.1007/BF01058901.
4
Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.用于体外分析的抗肿瘤药物制剂在制备和储存过程中的稳定性。III. 抗代谢物、微管蛋白结合剂、铂类药物、安吖啶、L-天冬酰胺酶、干扰素、类固醇及其他各类抗肿瘤药物
Cancer Chemother Pharmacol. 1989;23(4):197-207. doi: 10.1007/BF00451642.
5
Clinical pharmacokinetics of prednisone and prednisolone.泼尼松和泼尼松龙的临床药代动力学
Clin Pharmacokinet. 1990 Aug;19(2):126-46. doi: 10.2165/00003088-199019020-00003.
Prednisolone binding to albumin and transcortin in the presence of cortisol.
在皮质醇存在的情况下,泼尼松龙与白蛋白和皮质激素转运蛋白的结合。
Biochem Pharmacol. 1982 Feb 1;31(3):289-92. doi: 10.1016/0006-2952(82)90172-1.
5
Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non-cushingoid patients.库欣综合征患者和非库欣综合征患者中泼尼松龙的药代动力学及内源性氢化可的松水平
Eur J Clin Pharmacol. 1981;21(3):235-42. doi: 10.1007/BF00627926.
6
Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone.内源性氢化可的松,可能是导致服用泼尼松的患者出现库欣样体型的一个因素。
J Clin Endocrinol Metab. 1981 Nov;53(5):1076-80. doi: 10.1210/jcem-53-5-1076.
7
Endogenous and exogenous glucocorticoids in cushingoid patients.库欣综合征患者体内的内源性和外源性糖皮质激素。
Drug Intell Clin Pharm. 1982 Nov;16(11):863-8. doi: 10.1177/106002808201601109.
8
Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans.利用平衡透析法进行的容量转移和蛋白质结合估计:在人体中泼尼松龙结合的应用。
J Pharm Sci. 1983 Dec;72(12):1442-6. doi: 10.1002/jps.2600721218.
9
The simultaneous estimation of plasma cortisol and transcortin binding characteristics by a competitive protein binding technique.通过竞争性蛋白质结合技术同时测定血浆皮质醇和皮质素结合特性。
Steroids. 1969 Dec;14(6):705-15. doi: 10.1016/s0039-128x(69)80077-2.
10
Prednisone side-effects and serum-protein levels. A collaborative study.泼尼松的副作用与血清蛋白水平。一项合作研究。
Lancet. 1971 Oct 9;2(7728):778-80. doi: 10.1016/s0140-6736(71)92738-3.